← Leaderboards
Yanis Boumber
Research Inst Of Fox Chase Can Ctr
$2,133,668
Attributed
$2,133,668
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $617.6K · FY2018–22$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,133,668 · 2
By mechanism
R01$1,934,655 · 1
R21$199,013 · 1
Top collaborators
No co-investigators on record.
Most similar at Research Inst Of Fox Chase Can Ctr
Same institution · by research overlap
- Erica A Golemis$12,682,758
- Petr B. Makhov$1,568,231
- Zeng-Jie Yang$4,293,488
- James Stuart Duncan$3,237,626
Others in their field
Other Emerging Leaders on “Future”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- John E West · University Of Texas At Austin$128,483,161
- Beth Baseler · Leidos Biomedical Research, Inc.$117,364,154
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
Research focus
FutureIndividualized MedicineDrug ResistanceExperimental StudyComplementHuman TissueAutomobile DrivingAllelesCessation Of LifeEpithelialBiological MarkersAffectCancer Cell LineClinical TrialsCancer EtiologyCancer ModelCancer PatientBaseCause Of DeathAdenocarcinomaCell LineDrug TargetingCellsInvestigation
Grant awards (6)
Targeting Musashi-2 (MSI2) regulation of VEGFR2/VEGF-A in lung cancer$362,152
R01 · FY2022 · CA · contact PI
Targeting Musashi-2 (MSI2) regulation of VEGFR2/VEGF-A in lung cancer$371,289
R01 · FY2021 · CA · contact PI
Targeting Musashi-2 (MSI2) regulation of VEGFR2/VEGF-A in lung cancer$376,547
R01 · FY2020 · CA · contact PI
Targeting Musashi-2 (MSI2) regulation of VEGFR2 / VEGF-A in lung cancer$406,054
R01 · FY2019 · CA · contact PI
Targeting Musashi-2 (MSI2) regulation of VEGFR2 / VEGF-A in lung cancer$418,613
R01 · FY2018 · CA · contact PI
Targeting Musashi-2 (MSI2) regulation of EGFR and HER2 in lung cancer$199,013
R21 · FY2018 · CA · contact PI